THE THERAPEUTIC USE OF 2,3-DIMERCAPTOPROPANE-1-SULFONATE IN 2 CASES OF INORGANIC MERCURY-POISONING

被引:51
作者
CAMPBELL, JR [1 ]
CLARKSON, TW [1 ]
OMAR, MD [1 ]
机构
[1] UNIV ROCHESTER,SCH MED,DEPT TOXICOL,ROCHESTER,NY 14627
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1986年 / 256卷 / 22期
关键词
D O I
10.1001/jama.256.22.3127
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3127 / 3130
页数:4
相关论文
共 23 条
[1]  
BATTIGELLI M C, 1960, J Occup Med, V2, P394, DOI 10.1097/00043764-196008000-00006
[2]  
BATTIGELLI M C, 1960, J Occup Med, V2, P337, DOI 10.1097/00043764-196007000-00009
[3]  
BELONOZHKO G A, 1958, Farmakol Toksikol, V21, P69
[4]  
CHERIAN MG, 1976, ARCH ENV HLTH, V31, P302
[5]  
CHISOLM JJ, 1970, PEDIATR CLIN N AM, V17, P591
[6]  
CLARKSON TW, 1981, J PHARMACOL EXP THER, V218, P74
[7]  
CLARKSON TW, 1977, CLIN CHEM CHEM TOXIC, P189
[8]  
CLARKSON TW, 1977, CLIN CHEM CHEM TOXIC, P201
[9]   EXCRETION AND DISTRIBUTION OF INORGANIC MERCURY IN RAT AS INFLUENCED BY SEVERAL CHELATING-AGENTS [J].
GABARD, B .
ARCHIVES OF TOXICOLOGY, 1976, 35 (01) :15-24
[10]   CLINICAL TOXICOLOGY OF MERCURY [J].
GERSTNER, HB ;
HUFF, JE .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1977, 2 (03) :491-526